BackgroundCheck.run
Search For

Yanan N Zhang, 51Livingston, NJ

Known as:
Ya Nan Zhang Ya N Zhang
Related to:
Tong Jian Zhang

Yanan Zhang Phones & Addresses

Livingston, NJ   

Chesterbrook, PA   

Cary, NC   

Northville, MI   

Durham, NC   

Troy, MI   

Farmington Hills, MI   

Westland, MI   

Detroit, MI   

Get Report
Control this profile

Mentions for Yanan N Zhang

Yanan Zhang resumes & CV records

Resumes

Yanan Zhang Photo 27

Accountant

Location:
Philadelphia, PA
Industry:
Accounting
Work:
Kregel & Company Cpa
Accountant Private Wholesale Company Apr 2010 - Dec 2013
Accountant
Education:
Walsh College 2005 - 2009
Walsh College 2007 - 2008
Masters, Finance
Skills:
Cpa, Accounting, Xero, Tax, Thomson Reuters Ultratax Cs, Adp Payroll, Financial Reporting, Financial Accounting, Financial Statements, Cpa Candidate, Auditing, Financial Analysis, Internal Controls, General Ledger, Account Reconciliation, Sarbanes Oxley Act
Interests:
Social Services
Children
Education
Environment
Science and Technology
Disaster and Humanitarian Relief
Health
Languages:
English
Yanan Zhang Photo 28

Yanan Zhang

Yanan Zhang Photo 29

Yanan Zhang

Yanan Zhang Photo 30

Yanan Zhang

Yanan Zhang Photo 31

Yanan Zhang

Yanan Zhang Photo 32

Yanan Zhang

Publications & IP owners

Us Patents

Diaryl Purine Derivatives With Improved Bioavailability

US Patent:
2019035, Nov 21, 2019
Filed:
Dec 20, 2017
Appl. No.:
16/472155
Inventors:
- Research Triangle Park NC, US
Robert W. Wiethe - Durham NC, US
Yanan Zhang - Apex NC, US
George S. Amato - Cary NC, US
International Classification:
C07D 473/34
C07D 471/10
Abstract:
This disclosure is directed to various compounds and methods of preparation of improved compounds that are capable of functioning as cannabinoid receptor 1 (CB1) antagonists with reduced central nervous system (CNS) side effects. The application is also directed to pharmaceutical compositions containing one or more of these compounds, which may also contain one or more additional therapeutic agents. It is also directed to methods of treatment of various conditions that may be responsive to antagonism of the CB1 receptors, including, but not limited to, metabolic syndromes (including liver disease, obesity, and diabetes).

Peripherally Restricted Diphenyl Purine Derivatives

US Patent:
2016004, Feb 18, 2016
Filed:
Oct 26, 2015
Appl. No.:
14/922583
Inventors:
- Research Triangle Park NC, US
Alan Bradley Fulp - Willow Spring NC, US
Yanan Zhang - Apex NC, US
Herbert H. Seltzman - Raleigh NC, US
International Classification:
C07D 473/34
Abstract:
The invention provides compounds capable of acting as antagonists at cannabanoid receptors according to the following formula:Such compounds may be used to treat conditions for which the cannabinoid receptor system has been implicated, such as obesity, liver disease, diabetes, pain, and inflammation.

Composition And Method For Neuropeptide S Receptor (Npsr) Antagonists

US Patent:
2015005, Feb 26, 2015
Filed:
Dec 6, 2012
Appl. No.:
14/363079
Inventors:
- Research Triangle Park NC, US
Yanan Zhang - Apex NC, US
Carla Hassler - Durham NC, US
Brian Gilmour - Mebane NC, US
Assignee:
RESEARCH TRIANGLE INSTITUTE - Research Triangle Park NC
International Classification:
C07D 491/048
C07D 491/107
US Classification:
51421707, 546115, 514302, 540597, 546 15, 514278, 544362, 51425304
Abstract:
Neuropeptide S receptor antagonists are provided that bind in functional assays to neuropeptide S receptors; methods are provided for use of these antagonists in treatment of conditions or disease states that are ameliorated by blocking of the neuropeptide S receptor, including substance abuse and substance abuse relapse; and for use of neuropeptide S receptor antagonists in the manufacture of therapeutics and pro-drugs for therapeutics useful in disease states and conditions sensitive to binding of the neuropeptide S receptor.

Peripherally Restricted Diphenyl Purine Derivatives

US Patent:
2015003, Jan 29, 2015
Filed:
Feb 15, 2013
Appl. No.:
14/378479
Inventors:
- Research Triangle Park NC, US
Alan Bradley Fulp - Willow Spring NC, US
Yanan Zhang - Apex NC, US
Herbert H. Seltzman - Raleigh NC, US
International Classification:
C07D 473/34
US Classification:
5142285, 51426322, 5142634, 544 61, 544277
Abstract:
The invention provides compounds capable of acting as antagonists at cannabanoid receptors according to the following formula: Such compounds may be used to treat conditions for which the cannabinoid receptor system has been implicated, such as obesity, liver disease, diabetes, pain, and inflammation.

Pyrazole Derivatives As Cannabinoid Receptor 1 Antagonists

US Patent:
2014010, Apr 17, 2014
Filed:
Jun 15, 2012
Appl. No.:
14/126194
Inventors:
Alan Bradley Fulp - Willow Spring NC, US
Rangan Maitra - Cary NC, US
Yanan Zhang - Apex NC, US
Herbert H. Seltzman - Raleigh NC, US
Assignee:
Research Triangle Institute - Research Triangle Park NC
International Classification:
C07D 231/14
C07D 401/06
C07D 401/12
US Classification:
514326, 5462754, 514341, 5483741, 514406, 546211
Abstract:
The invention provides compounds capable of acting as antagonists at cannabanoid receptors according to the following formula: Such compounds may be used to treat conditions for which the cannabinoid receptor system has been implicated, such as obesity, liver disease, diabetes, pain, and inflammation.

Possible Relatives

David Zhang  Dawei Zhang  Dazhi Zhang  De K Zhang  Da Q Zhang  Dachuan Zhang  Daijun Zhang  Yanan Liu  Yanan Xu  Yanan T Luo 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.